#PatientStories
Meet Mr Prashant Varma, our braveheart volunteer, diagnosed with myositis in 2020 after visiting multiple doctors. For him, finally getting a diagnosis was bittersweet.
Register: https://t.co/PuX7yajzGN
Donate: https://t.co/NAdXSIeiHu
#MyositisIndia@docrota
This Myositis Awareness Month, we share the inspiring journey of our ambassador @Samanthaprabhu2 , who faced Myositis with courage and continues to inspire patients, caregivers, & supporters.
@Myositis_India is here for you at every step.
Donate: https://t.co/NAdXSIeiHu
@docrota
Join Myositis India for the Physician Webinar on “Interferons in IIM” on 31 May 2026 | 8 PM IST.
Featuring Dr. Akira Yoshida & Dr. Rudrarpan Chatterjee.
Register here: https://t.co/wn2Mp8MFYD
#Myositis#Rheumatology#IIM
Understanding Interferons in IIM: from pathogenesis to clinical relevance.
Join Myositis India for a webinar on interferon signatures, their role in IIM, and what it means for clinical practice.
🗓 31 May 2026
⏰ 8 PM IST
📍 Zoom
Scan QR to register.
One voice can inspire thousands to feel seen, heard, & hopeful. More than an interview — a conversation that brings strength to the myositis community. Grateful to Samantha Ruth Prabhu a Bollywood star for using her voice to spread myositis awareness.
Wishing Samantha Ruth Prabhu (@Samanthaprabhu2) a very Happy Birthday! 🎂💙
Her courage in openly sharing her myositis journey has been a beacon of hope for countless patients across India. Today, the entire myositis community comes together to celebrate her strength, resilience, and the powerful voice she lends to our cause. Your strength gives us hope. Your voice helps us be heard. 🌿
#HappyBirthdaySamantha #MyositisIndia #StrengthSupportAwareness #SamanthaRuthPrabhu
The most exciting news ever for myositis pts: a novel oral JAK1/TYK2 inhibitor (brepocitinib) shows positive Phase 3 results in dermatomyositis. Honored to part of the VALOR & NEJM- grateful to our patients, investigators, and Priovant. FDA Approval soon. https://t.co/tcbvmrpOBw
Clinical trials aren’t optional in myositis, they’re the backbone of evidence-based care.
Join leading experts to discuss key challenges, barriers, and the way forward.
🗓 8 Feb 2026 | SUNDAY |⏰ 7 PM IST
📲 Register via QR
#Myositis#ClinicalTrials#Rheumatology
Clinical trials aren’t optional in myositis, they’re the backbone of evidence-based care.
Join leading experts to discuss key challenges, barriers, and the way forward.
🗓 8 Feb 2026 | SUNDAY |⏰ 7 PM IST
📲 Register via QR
#Myositis#ClinicalTrials#Rheumatology
Sharing our editorial on CTD-ILD in Rheumatology (Oxford). Thanks to Dr. Shiri Keret and Daniel Sullivan for this article. Interstitial lung disease in connective tissue diseases: evolving strategies across the disease spectrum https://t.co/qpKP3o4Eoi
Looking for a Project Manager for MCTC (Remote work position). See job posting below. Exciting work in scientific and global environments for a rare disease organization.
🚨 NEW DEADLINE The MCTC grants to support early-career investigators 👨🔬 attending the Global Conference on Myositis (GCOM) 2026 will be open for submissions for a couple of extra weeks! Applications are now due by November 15, 2025. #MCTC#GCOM2026#EarlyCareerResearchers
🚀 CANTRAIN is revolutionizing clinical trial research in Canada. Discover how their approach is transforming training, engagement & impact.📷 Join us on November 7 at 10:00 AM EST-->
https://t.co/MKF4FIZfxe📷🕓
Thanks to Dr. Takahisa Gono and team for reviewing Myositis Specific Antibody (MSA) accuracy among commercial assays. Beware of false -ve and +ve results for MSA esp LineBlot assay. Analytical performance of commercial myositis-specific autoantibody te... https://t.co/w2tkomdalW
#ACR2025 where Rheumatology science, innovation and joy of meeting mentees and colleagues come together ! Congratulations to my mentees for more than 10 posters and presentations this ACR on #myositis
Great pleasure to meet Lindsay who beat her dermatomyositis with CAR-T treatment. Great to know she is doing remarkably well off all myositis treatment. We need more such patient champions to share experiences with other patients going for transformative recovery with CAR-T. @bmsnews
Join our Physician Webinar on IVIG in Myositis!
🎙️ Dr. Joost Raaphorst & Dr. Sakir Ahmed
🗓️ 31st Oct | ⏰ 7 PM IST
Don’t miss this expert discussion
🔗 Register here: https://t.co/mF3ZnTV7B8
#MyositisIndia#IVIG#Webinar#Rheumatology